MORGAN STANLEY

Holdings History for Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Symbol: TRML
Investment type: Equity / Common stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025		-0%	$0	0	-252,093	-100%	$47.98	Q4 2025
30 Sep 2025	0%	-0%	$12,057,609	252,093	-110,643	-31%	$47.83	Q3 2025
30 Jun 2025	0%	+0%	$5,800,148	362,736	+76,991	+27%	$15.99	Q2 2025
31 Mar 2025	0%	+0%	$4,346,182	285,745	+81,463		$15.21	Q1 2025
31 Dec 2024	0%	-0%	$4,142,840	204,282	-33,467		$20.28	Q4 2024
30 Sep 2024	0%	-0%	$6,112,527	237,749	-90,193		$25.71	Q3 2024
30 Jun 2024	0%	+0%	$4,217,334	327,942	+311,623	+1900%	$12.86	Q2 2024
31 Mar 2024	0%	+0%	$373,706	16,319	+10,145	+164%	$22.90	Q1 2024
31 Dec 2023	0%	+0%	$161,636	6,174	+6,174	NEW	$26.18	Q4 2023

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.